Innovative ETFs Content Hub Consider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021 By Max ChenDecember 31, 2020
Innovative ETFs Content Hub Access Small Cap Opportunities in Health Care With PSCH By Ben HernandezDecember 22, 2020
Innovative ETFs Content Hub Biotech ETFs Tracking CRISPR Gene Editing Surge By Max ChenDecember 21, 2020
Equity ETF Content Hub Go Beyond Trends: Healthcare Megatrends with the IDNA ETF By Ben HernandezDecember 9, 2020
Disruptive Technology Content Hub Bad Ideas: The Industries on Innovation’s Chopping Block By Max ChenNovember 17, 2020
Thematic Investing Content Hub An ETF to Get In On Chinese Healthcare’s Banner Year By Ben HernandezNovember 16, 2020
Innovative ETFs Content Hub 5 Reasons Why Investors Should Consider a Healthcare ETF By Max ChenNovember 3, 2020
Webcasts America’s ‘Financial First Responders’ Examine the 2020 Election By Max ChenOctober 21, 2020
Disruptive Technology Content Hub Healthcare Presents Huge Opportunities for 3D Printing ETF By Tom LydonOctober 1, 2020
Innovative ETFs Content Hub An Outperforming ETF for a Post-Coronavirus Pandemic World By Max ChenAugust 27, 2020
Webcasts A Targeted Biotech ETF to Access Next-Gen Healthcare Opportunities By Max ChenAugust 27, 2020
Multifactor Content Hub How to Gain Exposure to the Next Generation of Healthcare By Max ChenAugust 26, 2020
Multifactor Content Hub Startup Opportunities Could Continue Fueling Healthcare Innovation ETFs By Ben HernandezJuly 23, 2020
Multifactor Content Hub Right Place, Right Time for Innovative Healthcare ETF By Tom LydonJuly 13, 2020
Innovative ETFs Content Hub Biotech ETFs Rally as ‘Operation Warp Speed’ Fuels Covid-19 Research By Max ChenJuly 7, 2020
Multifactor Content Hub Rising Coronavirus Numbers Makes Case for this Healthcare ETF By Ben HernandezJuly 7, 2020
